SKU: CP10≥ 99% HPLC
Ipamorelin/CJC-1295 (no DAC) 5MG/5MG
Research Compound · Research use only

Ipamorelin/CJC-1295 (no DAC) 5MG/5MGIpamorelin/CJC-1295 (no DAC) Blend combines two synthetic peptides for laboratory research.

$43.99/ vial · 10mg
In stock
Est. Arrival: 11/25/2026Ships today if ordered by 4PM EST
Select Size
Volume Discounts
1
Purity
99%+
Form
Lyophilized Powder
Quantity
10 mg
Storage
Store lyophilized at -20 °C, sealed, away from light and moisture
Batch / Lot
202609-01-CP
99%+ PurityHPLC · third-party
COA Includedlot 202609-01-CP
USA BasedMidwest Region
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
$43.99Ipamorelin/CJC-1295 (no DAC) 5MG/5MG · 10mg × 1

Product Details

Ipamorelin/CJC-1295 (no DAC) Blend combines two peptides:


Ipamorelin – Pentapeptide GHS-R agonist (Aib-His-D-2-Nal-D-Phe-Lys-NH2) with non-natural amino acids.


CJC-1295 (no DAC) – 29-amino acid tetrasubstituted GHRH analog (D-Ala2, Ala8, Leu15, Leu27) for proteolytic stability.


Combined lyophilized powder, soluble in sterile water or bacteriostatic water. Store at -20°C.


Disclaimer: For laboratory and research purposes only. Not intended for human consumption.

Frequently Asked Questions About Ipamorelin/CJC-1295 (no DAC) 5MG/5MG

Answers summarize published research and are provided for laboratory research purposes only.

Research studies describe the two components of the Ipamorelin/CJC-1295 (no DAC) blend as acting on separate pituitary receptors. Ipamorelin is a growth hormone secretagogue receptor agonist, and CJC-1295 (no DAC) is a GHRH receptor agonist. In animal models, researchers have reported that combining a secretagogue with a GHRH analog produced a larger growth hormone pulse than either agent alone, which is the rationale for pairing them in one vial.
The primary research area for the Ipamorelin/CJC-1295 (no DAC) blend is pituitary growth hormone secretion. Researchers have reported using paired secretagogue and GHRH analog protocols in rodent and pig studies to examine pulse amplitude, pulse timing, and downstream IGF-1 levels. The blend gives laboratories both classes at a fixed 5 mg to 5 mg ratio without weighing two separate powders.
The Ipamorelin/CJC-1295 (no DAC) blend uses the short-acting form of CJC-1295. CJC-1295 W/ DAC adds a drug affinity complex, a lysine-linked maleimide group that researchers have reported binds serum albumin and extends the half-life from minutes to days. In research studies, the no DAC form produced discrete growth hormone pulses, while the DAC form produced a sustained elevation. Biotech Compounds sells CJC-1295 W/ DAC separately.

Purity, documented